Objective: Our study was performed in order to assess the effects of magnesium sulfate during coronary artery bypass surgery to evaluate whether perioperative intravenous infusion of magnesium, as an adjuvant agent for perioperative analgesia, affects a quality of anesthesia, reduces amounts of anesthetic and muscle relaxing drugs needed, affects adrenaline usage and nitroglycerine during anesthesia.
Methods: We investigated two patient groups, undergoing a coronary artery bypass surgery. Thirty patients (control group) have not received intravenous infusion of magnesium, 31 patients (magnesium group) have received 40 mg/kg of intravenous magnesium sulfate initially and a continuous 500 mg/h infusion during anesthesia.
Unlabelled: The objective of this study was to evaluate usage possibilities of magnesium sulfate in anesthesiology.
Methodology: In Clinic of Cardiac Surgery, Kaunas University of Medicine magnesium sulfate was started for use as an adjuvant to anesthetics. For anesthesia it was used in 20 cases.